merck glp-1 agonist Comparing Ozempic, Wegovy and Other Drugs Merck pays $112M upfront for

Impact on Fertility Although GLP-1 receptor agonists are not classified as fertility medications like letrozole or clomiphene, they can enhance fertility indirectly by improving metabolic health

Policy and Implementation Research Countries with experience in navigating GLP-1 receptor agonist coverage decisions for people with obesity offer lessons for others now facing similar decisions or reconsidering their existing policies [86]

Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, et al

Moreover, awareness about obesity as a disease and the rising adoption of obesity management programs have created immense potential for market expansion

Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients

How do GLP-1s, like Zepbound or Wegovy, affect people with papillary thyroid cancer